Camden Property Trust (CPT) : During the past 4 weeks, traders have been relatively bearish on Camden Property Trust (CPT), hence the stock is down -6.02% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -3.33% relative to the S&P 500. The 4-week change in the price of the stock is -6.53% and the stock has fallen -3.17% in the past 1 week.
The stock has recorded a 20-day Moving Average of 0.5% and the 50-Day Moving Average is 1.2%.The 200 Day SMA reached 8.79%
Camden Property Trust (NYSE:CPT): The stock opened in the green at $85.32 on Friday, but the bulls found it difficult to push the prices higher. The stock reached a high of $85.49 and a low of $83.72 for the day. The stock did not find buyers even at the lows and closed at $83.74 recording a loss of -1.27%. 1,115,635 shares exchanged hands during the trading day. The stock had closed at $83.74 in the previous days trading.
Camden Property Trust (CPT) stock is expected to deviate a maximum of $7.34 from the average target price of $86.79 for the short term period. 14 Street Experts have initiated coverage on the stock with the most promising target being $101 and the most muted being $75.
Camden Property Trust is a real estate investment trust (REIT). The Company is engaged in the ownership, management, development, redevelopment, acquisition and construction of multifamily apartment communities. The Companies properties consist of mid-rise buildings or two and three story buildings in a landscaped setting and provide residents with various amenities common to multifamily rental properties. As of December 31, 2014, the Company owned interests in, operated or was developing 181 multifamily properties consisting of 63,163 apartment homes across the United States. The Companys properties include Camden Copper Square, Camden Montierra, Camden Sea Palms, Camden Tuscany, Camden Belleview Station, Camden Denver West, Camden Fallsgrove, Camden Summerfield, Camden Bay, Camden Brookwood and Camden Ballantyne, among others.